MedTrace Logo

Pilot Study on Improving Mobility and Universal Accessibility for Individuals With Visual Disabilities in Barcelona

NCT06602102 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2024-11-27

No results posted yet for this study

Summary

The project BCNMob informs about a research study approved by the Ethics Committee of the Hospital Universitario Mútua Terrassa

The study aims to improve the Biel Glasses virtual reality glasses to assist patients with low vision in detecting and locating objects during mobility. Optometric evaluations and training sessions will be conducted, followed by tests in an urban environment in Barcelona.

There are no significant risks associated with participation, although mild discomfort may arise. The information collected will be confidential and managed according to data protection legislation. No financial compensation will be offered.

Conditions

  • Low Vision Aids
  • Low Vision
  • Low Vision Blindness
  • Low Vision Digital Assistance

Interventions

DEVICE

Mixed reality Glasses

Mixed reality glasses are devices that combine elements of augmented reality and virtual reality. They allow users to overlay digital images onto the real world, enabling interaction with virtual objects in a physical environment. These glasses typically use sensors, cameras, and tracking technology to map the surroundings and provide an immersive experience. They are used in various applications, such as gaming, education, design, and professional training.

Sponsors & Collaborators

  • Universitat Politècnica de Catalunya

    lead OTHER

Principal Investigators

  • Joan Gispets, PhD · Universidad Politécnica de Catalunya

  • Salut Alba-Arbalat, PhD · Universidad Politécnica de Catalunya

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-22
Primary Completion
2024-11-12
Completion
2024-11-25

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06602102 on ClinicalTrials.gov